Aspen Technology Inc has reached agreement with Aventis, a market-leading global pharmaceutical company, to extend AspenTech's pharmaceutical manufacturing and compliance solution to Aventis´ primary and secondary manufacturing plants worldwide. The solution provides Electronic Batch Records, Data Historian, Data Analysis and Enterprise Integration. The agreement is a key element in the Aventis strategy to maintain compliance with current and future FDA requirements, including 21 CFR Part 11.

"We selected AspenTech after an intense study, and have assessed its solution to be the most complete and cost-effective available today," said Dr. Hanns E. Erle, Aventis Senior Vice President in Industrial Operations. "This agreement is expected to reduce the complexity in our business, contain the number of our software suppliers, and enable us to consider new ways of improving our manufacturing operations in partnership with AspenTech."

This new agreement provides a standard and complete solution that can be applied to all of Aventis´ worldwide manufacturing facilities.

"The endorsement of a world leader such as Aventis is an important validation of our Enterprise Operations Management solution for the pharmaceutical industry," said David McQuillin, President and CEO of AspenTech. "Our experience in driving cost out of manufacturing in other process industries, together with our investment in compliance solutions for pharmaceuticals, is a unique combination that offers a way for pharmaceutical companies to optimize their operations in the current challenging business environment."